Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer

International Journal of Cancer

Volumn 139, Issue 11, 2016, Pages 2583-2592

  Li, Xiu Juan ^a,b   Gangadaran, Prakash ^a   Kalimuthu, Senthilkumar ^a   Oh, Ji Min ^a   Zhu, Liya ^a   Jeong, Shin Young ^a   Lee, Sang Woo ^a   Lee, Jaetae ^a,c   Ahn, Byeong Cheol ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b TAIAN CITY CENTRAL HOSPITAL   (China)

^c Daegu Gyeongbuk Medical Innovation Foundation   (South Korea)

Author keywords

clodronate; lung metastasis initiation; macrophage; thyroid cancer

Indexed keywords

CLODRONIC ACID; LIPOSOME;

ANAPLASTIC THYROID CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL COUNT; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG METASTASIS; MACROPHAGE MIGRATION; METASTASIS INHIBITION; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYROID CANCER CELL LINE; TUMOR VOLUME;

EID: 84987971418     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30387     Document Type: Article

References (47)

1. Zaynagetdinov R, Sherrill TP, Polosukhin VV, et al. A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J Immunol 2011;187:5703–5711.
2. Qian B-Z, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39–51.
3. Ryder M, Ghossein RA, Ricarte-Filho JCM, et al. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 2008;15:1069–1074.
4. Jung KY, Cho SW, Kim YA, et al. Cancers with higher density of tumor-associated macrophages were associated with poor survival rates. J Pathol Transl Med 2015;49:318–324.
5. Fang W, Ye L, Shen L, et al. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8. Carcinogenesis 2014;35:1780–1787.
6. Kim S, Cho SW, Min HS, et al. The expression of tumor-associated macrophages in papillary thyroid carcinoma. Endocrinol Metab (Seoul) 2013;28:192–198.
7. Halin S, Rudolfsson SH, Van Rooijen N, et al. Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. Neoplasia 2009;11:177–186.
8. Reusser NM, Dalton HJ, Pradeep S, et al. Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer. Cancer Biol Ther 2014;15:1061–1067.
9. Yang DM, Chi CW, Chang HM, et al. Effects of clodronate on cancer growth and Ca2+ signaling of human thyroid carcinoma cell lines. Anticancer Res 2004;24:1617–1623.
10. Mathew A, Brufsky A. Bisphosphonates in breast cancer. Int J Cancer 2015;137:753–764.
11. Wang CH, Shen YC, Hsieh JJ, et al. Clodronate alleviates cachexia and prolongs survival in nude mice xenografted with an anaplastic thyroid carcinoma cell line 2006. J Endocrinoe 2006;190:415–423.
12. Zivaljevic V, Tausanovic K, Paunovic I, et al. Age as a prognostic factor in anaplastic thyroid cancer. Int J Endocrinol 2014;2014:240513.
13. Lim SM, Shin SJ, Chung WY, et al. Treatment outcome of patients with anaplastic thyroid cancer: A single center experience. Yonsei Med J 2012;53:352–357.
14. Besic N, Gazic B. Sites of metastases of anaplastic thyroid carcinoma: Autopsy findings in 45 cases from a single institution. Thyroid 2013;23:709–713.
15. Kim JE, Kalimuthu S, Ahn B-C. In vivo cell tracking with bioluminescence imaging. Nucl Med Mol Imaging 2015;49:3–10.
16. Ahn BC, Parashurama N, Patel M, et al. Noninvasive reporter gene imaging of human Oct4 (pluripotency) dynamics during the differentiation of embryonic stem cells in living subjects. Mol Imaging Biol 2014;16:865–876.
17. Kim HW, Kim JE, Hwang MH, et al. Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells. PLoS One 2013;8:1–18.
18. Weisser SB, van Rooijen N, Sly LM. Depletion and reconstitution of macrophages in mice. J Vis Exp 2012;1:4105.
19. Su S, Liu Q, Chen J, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 2014;25:605–620.
20. Schmall A, Al-Tamari HM, Herold S, et al. Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. Am J Respir Crit Care Med 2015;191:437–447.
21. Rey-Giraud F, Hafner M, Ries CH. In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PloS One 2012;7:e42656.
22. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Dev Camb Engl 2005;132:3151–3161.
23. Vega S, Morales AV, Ocaña OH, et al. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004;18:1131–1143.
24. Jung A, Schrauder M, Oswald U, et al. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 2001;159:1613–1617.
25. Svensson S, Nilsson K, Ringberg A, et al. Invade or proliferate? Two contrasting events in malignant behavior governed by p16INK4a and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res 2003;63:1737–1742.
26. Kim DH, Jung JH, Son SH, et al. Difference of clinical and radiological characteristics according to radioiodine avidity in pulmonary metastases of differentiated thyroid cancer. Nucl Med Mol Imaging 2014;48:55–62.
27. Oh JR, Ahn BC, Jeong SY, et al. Radioiodine scan index: A simplified, quantitative treatment response parameter for metastatic thyroid carcinoma. Nucl Med Mol Imaging 2015;49:174–181.
28. James ML, Gambhir SS. A molecular imaging primer: Modalities, imaging agents, and applications. Physiol Rev 2012;92:897–965.
29. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883–899.
30. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23–35.
31. Mantovani A, Sica A. Macrophages, innate immunity and cancer: Balance, tolerance, and diversity. Curr Opin Immunol 2010;22:231–237.
32. Ojalvo LS, King W, Cox D, et al. High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am J Pathol 2009;174:1048–1064.
33. Ojalvo LS, Whittaker CA, Condeelis JS, et al. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol 2010;184:702–712.
34. Koay MA, Gao X, Washington MK, et al. Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. Am J Respir Cell Mol Biol 2002;26:572–578.
35. van Rooijen N, van Kesteren-Hendrikx E. Clodronate liposomes: Perspectives in research and therapeutics. J Liposome Res 2002;12:81–9431.
36. van Rooijen N, Hendrikx E. Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol Biol 2010;605:189–203.
37. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 2002;196:254–265.
38. Chen JJ, Lin YC, Yao PL, et al. Tumor-associated macrophages: The double-edged sword in cancer progression. J Clin Oncol 2005;23:953–964.
39. Kim DW, Min HS, Lee KH, et al. High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer 2008;98:1118–1124.
40. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71–78.
41. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 2010;141:52–67.
42. Wang J, Cao Z, Zhang XM, et al. Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development. Cancer Res 2015;75:306–315.
43. Bozinovski S, Vlahos R, Anthony D, McQualter J, Anderson G, Irving L, Steinfort D. COPD and squamous cell lung cancer: Aberrant inflammation and immunity is the common link. Br J Pharmacol 2016;173:635–648.
44. Woode D, Shiomi T, D'Armiento J. Collagenolytic matrix metalloproteinases in chronic obstructive lung disease and cancer. Cancers (Basel) 2015;7:329–341.
45. Beckett EL, Stevens RL, Jarnicki AG, et al. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy ClinImmunol 2013;131:752–762.
46. Inhestern J, Oertel K, Stemmann V, et al. Prognostic role of circulating tumor cells during induction chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer. Plos One 2015;10:e0132901.
47. Pesta M, Fichtl J, Kulda V, et al. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Anticancer Res 2013;33:2239–2244.